Hope and skepticism abound around Biogen and Eisai Alzheimer ’s trial

An antibody called BAN2401 cleared amyloid- β proteins and slowed cognitive decline in people with mild Alzheimer’s disease

Source: NanoFocus - July 27, 2018 Category: Nanotechnology Authors: Ryan Cross Source Type: research